News

Search here results

• Identification of SCA3 biomarkers: an interview with Dr Hector Garcia-Moreno | UCL Queen Square Institute of Neurology - UCL – University College London
• Professor Sarah Tabrizi receives 2022 Osler Medal and HDSA 2022 Research Award | UCL Queen Square Institute of Neurology - UCL – University College London
• New £4.25m grant kick starts UK-wide collaborative research effort to end motor neuron disease | UCL Queen Square Institute of Neurology - UCL – University College London
• Landmark review about disease-modifying therapies in Huntington’s disease published | UCL Queen Square Institute of Neurology - UCL – University College London
• New system that defines Huntington’s Disease will ‘revolutionise’ drug trials | UCL Queen Square Institute of Neurology - UCL – University College London
• Turkish ICGNMD Team meet | International Centre for Genomic Medicine in Neuromuscular Diseases - UCL – University College London
• Rise in Guillain-Barré syndrome following AstraZeneca vaccine | UCL Queen Square Institute of Neurology - UCL – University College London
• Integrated human disease research projects awarded £7 million | UCL Queen Square Institute of Neurology - UCL – University College London
• At-home blood test for juvenile-onset Huntington’s disease to be trialled | UCL Queen Square Institute of Neurology - UCL – University College London
• Time Capsule buried in UCL's world-class centre for neuroscience as part of Dementia Action Week | UCL Queen Square Institute of Neurology - UCL – University College London